MYND Life Sciences Inc.
MYND Life Sciences Inc.
CSE Index:
Currency:
Mynd is a life sciences based neuro-pharmaceutical drug development company advancing medicines that leverage psychedelic compounds. Our mission is to further our existing research and patents linking depression and inflammation at the genetic and cellular level to develop pharmaceutical treatments.
MYND Life Sciences Inc. (MYND)
SEDAR Information
Company Info
Address
105 - 2248 Elgin Ave
Port Coquitlam, BC V3C 2B2
CanadaPhone
780-965-0122Email
lyleo@myndsciences.comWebsite
http://www.myndsciences.comListing date
Wednesday, May 26, 2021Transfer Agent
Odyssey Trust CompanyAuditor
MNP LLPCapitalization
Issued & Outstanding:
46,817,182Reserved for Issuance:
10,430,000Company Officers
Dr. Wilfred Jefferies, Chief Science Officer
Dr. Lyle Oberg, Chief Executive Officer
Lih-Ming Tam, Interim Chief Financial Officer
News Releases
Bulletins
25/05/2021
2021-0537 – New Listing - MYND Life Sciences Inc. (MYND)
Le 25 mai/May 2021
The common shares of MYND Life Sciences Inc., have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
Advertisement
Publicité
Upcoming Events
Benzinga Cannabis Capital Conference
Tuesday, April 11, 2023 - 8:00am to Wednesday, April 12, 2023 - 5:00pm
